Infectious Diseases/Vaccines

Based on AMMI Canada’s 2025–26 seasonal influenza guideline update, which statement about treating influenza with the new antiviral baloxavir (Xofluza) is FALSE?

National Advisory Committee on Immunization addresses risk groups, dosage schedules, routes of administration and vaccine interchangeability.

An oral, at-home HIV test that delivers results in as little as 20 minutes and has been used in the U.S. for well over a decade is finally coming to Canada.

Senior author Dr. Derek Chu says researchers analyzed more than 190 food allergy studies from around the world to identify the strongest risk factors in developing food allergies.

Public Health Agency of Canada issues a comprehensive list of resources to aid, inform and educate Canadian healthcare professionals providing travel medicine services.

There may be a new way to slow the growth of glioblastoma with a medication already on the pharmacy shelf, new Canadian research finds.

Updated guidance stresses the importance of vaccination and answers three key questions about influenza and antiviral use for the 2025–26 season.

People with diabetes are at higher risk for complications from vaccine-preventable diseases, even if their blood glucose levels are well controlled.